Back
52· Steady
Health & Science3h 54m ago
Germany has green-lit the EU’s first psilocybin compassionate use program, with two centers, OVID Clinic Berlin and CIMH Mannheim, permitted to offer dosing.
Archive Window: 7 Days Left
Berlin, Mannheim, Germany
Who
Lea Mertens and Andrea Jungaberle
What
Germany has green-lit the EU’s first psilocybin compassionate use program, with two centers, OVID Clinic Berlin and CIMH Mannheim, permitted to offer dosing.
When
Tue, 16 Jun 2026 10:11:55 GMT · 3h 54m ago
Where
Berlin, Mannheim, Germany ·
Why
The program allows patients with specific conditions to access psilocybin treatment outside of clinical trials.
The Frontline Impact
How this affects you
This pioneering program in Germany, the first of its kind in the EU, is exploring insurance coverage for psilocybin treatment, potentially setting a precedent for broader accessibility of psychedelic medicine in Europe.
Story chain
4 events in this thread- Health & Science3h 54m agoGermany's psilocybin compassionate use program is underway with early patient experiences and progress in securing insurance coverage.Open article
- Health & Science3h 54m agoGermany's medicines regulator green-lit a psilocybin compassionate use program, the first in the European Union.Open article
- Currently Reading3h 54m agoGermany has green-lit the EU’s first psilocybin compassionate use program, with two centers, OVID Clinic Berlin and CIMH Mannheim, permitted to offer dosing.
- Health & Science3h 54m agoGermany’s medicines regulator green-lit a psilocybin compassionate use program, the first such pathway in the European Union.Open article